Recent press releases
New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring’s Subcutaneous C1-Esterase Inhibitor in HAE Patients
New England Journal of Medicine Publishes Phase 1b Results for Shire’s Investigational Treatment for Hereditary Angioedema, a Rare Genetic Disease
WHO WE ARE
The US HAEA is a non-profit patient advocacy organization dedicated to serving persons with angioedema.
We provide patients and families with a support network and wide range of services.
Executive Vice President
Contact Janet Long